Q-Line Biotech SME IPO opens today.
I recently visited their Lucknow manufacturing facility and spent time understanding the business, management and industry dynamics first-hand.
Some notes & observations from the ground 👇(1/10)
This Diwali, let your investments shine as bright as your celebrations!
We’re lighting up this Diwali with a special 35% OFF on our Smallcase portfolios.
Code: DIWALI35
Validity: Till 31st October 2025
Link: https://t.co/urFFZa4BuA
@nid_rockz @TiltQuest
SolarWorld Energy Solutions
#SolarWorld
FY26E:
Rev of 1500-1600cr with PAT margins of 11-13%
Guidance:
Current order book is approximately 2,500 crores.
Execution timeline is typically 12-18 months
The company is targeting to execute about 60% of the order book (roughly 1,500 crores) in FY26
Margin Expectations:
While FY25 PAT margins were high (15-16%), the sustainable industry standard for EPC projects is typically 10% to 11%.
Management expects margins to improve as backward integration becomes operational.
Executed and Current Projects: As of July 31, 2025, Solar World had executed 46 solar projects (aggregating 253 MW AC / 340 MW DC).
Currently, they are executing projects totalling approximately 765 MW AC and 994 MW DC for solar EPC, as well as around 650 MWh in BESS.
The Rurki facility's 1.2 GW topcon solar module line commenced operations in August 2025 and is now fully functional. The company intends to utilise 70% to 80% of this capacity internally to support the EPC business.
Upcoming Capacity Expansion:
BESS Line: A 3.4 GW-hour lithium-ion cell-to-battery pack assembly line is expected to be operational by January 2026.
Junction Box Line:
Expected to be operational by the end of FY26
Solar Cell Line: A 1.2 GW solar cell manufacturing line at Kandorna is targeted to be operational between December 2026 and March 2027.
Prepared by @TiltQuest
Food Delivery giants, Q-commerce and logistics services providers can face margin pressure due to a shift in GST Liability.
As the GST Council has clarified, the local delivery services will now be taxed at 18% GST to e-commerce operators from unregistered gig-workers.
Patience often outperforms constant activity in investing.
In this video, we share why our smallcases aren’t rebalanced too frequently and how staying disciplined can help investors benefit from the bigger picture.
@nid_rockz@TiltQuest#PINCWealth#PINCFamily
In Aug, the Indian Pharmaceutical Market grew by 8.7% to 20,984 Cr with a modest volume growth of 1.2%.
Growth led by?
Cardiac segments which grew by 13.2%, Anti-diabetics by 9.4% and Anti-Neoplastics by 19.7%
Below is a Thread from a interview by Chandrakant Sampath (The guru of Rakesh Jhunjhunwala (RJ) and Radhakishan Damani (RK Damani).) with Chetan Parikh
More thread to be followed :-
A must read thread